Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,681.41
(
-0.52%
)
US TECH 100
24,051.20
(
-0.34%
)
Dow Jones
46,606.40
(
-0.82%
)
Brent Oil
105.73
(
5.05%
)
Bitcoin
71,284.42
(
-3.59%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 79025

Monday, 10/12/2009 9:21:23 AM

Monday, October 12, 2009 9:21:23 AM

Post# of 257253
As CSL’s Berinert is approved first for the treatment of acute HAE, it will block Cinryze from the market for this indication in the US for 7 years, due to its orphan drug status.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now